{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:58:55Z","timestamp":1777658335979,"version":"3.51.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00501","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T04:36:06Z","timestamp":1594701366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Activin-A Induces Fewer, but Larger Osteoclasts From Monocytes in Both Healthy Controls and Fibrodysplasia Ossificans Progressiva Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Ton","family":"Schoenmaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esm\u00e9e","family":"Botman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Sariyildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Micha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen","family":"Netelenbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bravenboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angele","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Marelise W.","family":"Eekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teun J.","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.berh.2007.11.007","article-title":"Fibrodysplasia ossificans progressiva. best practice and research","volume":"22","author":"Kaplan","year":"2008","journal-title":"Clin Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1750-1172-6-80","article-title":"Fibrodysplasia ossificans progressiva: clinical and genetic aspects","volume":"6","author":"Pignolo","year":"2011","journal-title":"Orphanet J Rare Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ejhg.2014.274","article-title":"Clinical utility gene card for: fibrodysplasia ossificans progressiva","volume":"23","author":"Bravenboer","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000365770","article-title":"Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation","volume":"5","author":"Huning","year":"2014","journal-title":"Mol Syndromol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1359\/jbmr.071030","article-title":"Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP)","volume":"23","author":"Billings","year":"2008","journal-title":"J Bone Miner Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"22542","DOI":"10.1074\/jbc.M109.094557","article-title":"Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva","volume":"285","author":"Song","year":"2010","journal-title":"J Biol Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1359\/JBMR.050305","article-title":"Fibrodysplasia Ossificans Progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA","volume":"20","author":"de la Pena","year":"2005","journal-title":"J Bone Miner Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1359\/jbmr.060215","article-title":"Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP)","volume":"21","author":"Fiori","year":"2006","journal-title":"J Bone Miner Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1196\/annals.1346.008","article-title":"Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva","volume":"1068","author":"Kaplan","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12964-015-0104-z","article-title":"Activin A Inhibits BMP-signaling by Binding ACVR2A and ACVR2B","volume":"13","author":"Olsen","year":"2015","journal-title":"Cell Commun Signal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Transl Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/bcp.13777","article-title":"Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)","volume":"85","author":"Hsiao","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed Res Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","article-title":"Osteoclast-osteoblast communication","volume":"473","author":"Matsuo","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"B17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00774-006-0725-9","article-title":"Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood","volume":"25","author":"Sorensen","year":"2007","journal-title":"J Bone Miner Metabol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bone.2017.07.007","article-title":"Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva","volume":"109","author":"de Vries","year":"2018","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.1002\/jcp.27693","article-title":"The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva","volume":"234","author":"Schoenmaker","year":"2018","journal-title":"J Cell Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Human Mutation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1093\/hmg\/ddu255","article-title":"ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant","volume":"23","author":"Haupt","year":"2014","journal-title":"Human Mol Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/jcp.25220","article-title":"Different blood-borne human osteoclast precursors respond in distinct ways to IL-17A","volume":"231","author":"Sprangers","year":"2016","journal-title":"J Cell Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0139564","DOI":"10.1371\/journal.pone.0139564","article-title":"The foreign body giant cell cannot resorb bone, but dissolves hydroxyapatite like osteoclasts","volume":"10","author":"ten Harkel","year":"2015","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1016\/j.biomaterials.2014.05.048","article-title":"Barrere-de Groot, and de Bruijn JD, Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture","volume":"35","author":"Davison","year":"2014","journal-title":"Biomaterials."},{"key":"B25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bone.2017.11.014","article-title":"Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP)","volume":"109","author":"Wang","year":"2017","journal-title":"Bone"},{"key":"B26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Therapy."},{"key":"B27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fimmu.2019.00505","article-title":"What are the peripheral blood determinants for increased osteoclast formation in the various inflammatory diseases associated with bone loss?","volume":"10","author":"de Vries","year":"2019","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1210\/endo.143.1.8580","article-title":"Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures","volume":"143","author":"Gaddy-Kurten","year":"2002","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.1002\/jcb.26906","article-title":"Mechanisms involved in enhancement of osteoclast formation by activin-A","volume":"119","author":"Kajita","year":"2018","journal-title":"J Cell Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1242\/jcs.157834","article-title":"Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures","volume":"128","author":"Fowler","year":"2015","journal-title":"J Cell Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1242\/jcs.156737","article-title":"Loss of BMPR2 leads to high bone mass due to increased osteoblast activity","volume":"128","author":"Lowery","year":"2015","journal-title":"J Cell Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"37230","DOI":"10.1074\/jbc.M113.496950","article-title":"Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis","volume":"288","author":"Broege","year":"2013","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jcb.25092","article-title":"Smad1\/5 and Smad4 expression are important for osteoclast differentiation","volume":"116","author":"Tasca","year":"2015","journal-title":"J Cell Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0203404","DOI":"10.1371\/journal.pone.0203404","article-title":"SMAD1\/5 signaling in osteoclasts regulates bone formation via coupling factors","volume":"13","author":"Tasca","year":"2018","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jcp.22012","article-title":"RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens","volume":"223","author":"Mensah","year":"2010","journal-title":"J Cell Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17818","DOI":"10.1074\/jbc.RA119.009521","article-title":"Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway","volume":"294","author":"Omi","year":"2019","journal-title":"J Biol Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1056\/NEJMoa0802633","article-title":"Giant osteoclast formation and long-term oral bisphosphonate therapy","volume":"360","author":"Weinstein","year":"2009","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bone.2013.10.024","article-title":"Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients","volume":"59","author":"Jobke","year":"2014","journal-title":"Bone"},{"key":"B40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF00185977","article-title":"The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro","volume":"186","author":"Piper","year":"1992","journal-title":"Anat Embryol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbrc.2011.04.120","article-title":"Jaw and long bone marrow derived osteoclasts differ in shape and their response to bone and dentin","volume":"409","author":"Azari","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/jbmr.3235","article-title":"The expansion of heterotopic bone in fibrodysplasia ossificans progressiva is Activin A-dependent","volume":"32","author":"Upadhyay","year":"2017","journal-title":"J Bone Miner Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/bcp.13823","article-title":"Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva","volume":"85","author":"Wentworth","year":"2018","journal-title":"Br J Clin Pharmacol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00501\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T04:36:08Z","timestamp":1594701368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00501\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":43,"alternative-id":["10.3389\/fendo.2020.00501"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00501","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"501"}}